These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28134524)

  • 1. Monod-Wyman-Changeux Analysis of Ligand-Gated Ion Channel Mutants.
    Einav T; Phillips R
    J Phys Chem B; 2017 Apr; 121(15):3813-3824. PubMed ID: 28134524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic receptors: From protein allostery to computational neuropharmacology.
    Cecchini M; Changeux JP
    Mol Aspects Med; 2022 Apr; 84():101044. PubMed ID: 34656371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analytic solution to the Monod-Wyman-Changeux model and all parameters in this model.
    Zhou G; Ho PS; van Holde KE
    Biophys J; 1989 Feb; 55(2):275-80. PubMed ID: 2713440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenic nicotinic receptor mutant interpreted in terms of the allosteric model.
    Edelstein SJ; Schaad O; Changeux JP
    C R Acad Sci III; 1997 Dec; 320(12):953-61. PubMed ID: 9587473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric proteins after thirty years: the binding and state functions of the neuronal alpha 7 nicotinic acetylcholine receptors.
    Edelstein SJ; Changeux JP
    Experientia; 1996 Dec; 52(12):1083-90. PubMed ID: 8988250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thinking in cycles: MWC is a good model for acetylcholine receptor-channels.
    Auerbach A
    J Physiol; 2012 Jan; 590(1):93-8. PubMed ID: 21807612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical mechanics of Monod-Wyman-Changeux (MWC) models.
    Marzen S; Garcia HG; Phillips R
    J Mol Biol; 2013 May; 425(9):1433-60. PubMed ID: 23499654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photo-induced covalent attachment of agonists as a tool to study allosteric mechanisms of nicotinic acetylcholine receptors.
    Mourot A; Kotzyba-Hibert F; Goeldner M; Bamberg E
    J Mol Neurosci; 2006; 30(1-2):3-4. PubMed ID: 17192602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hill coefficients of a polymodal Monod-Wyman-Changeux model for ion channel gating.
    Qin F
    Biophys J; 2010 Aug; 99(3):L29-31. PubMed ID: 20682245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the estimation of cooperativity in ion channel kinetics: activation free energy and kinetic mechanism of Shaker K+ channel.
    Banerjee K; Das B; Gangopadhyay G
    J Chem Phys; 2013 Apr; 138(16):165102. PubMed ID: 23635173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of valine 7' of TMD2 to gating of neuronal alpha3 receptor subtypes.
    Nieves-Cintrón M; Caballero-Rivera D; Navedo MF; Lasalde-Dominicci JA
    J Neurosci Res; 2006 Dec; 84(8):1778-88. PubMed ID: 17044037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constraining ligand-binding site stoichiometry suggests that a cyclic nucleotide-gated channel is composed of two functional dimers.
    Liu DT; Tibbs GR; Paoletti P; Siegelbaum SA
    Neuron; 1998 Jul; 21(1):235-48. PubMed ID: 9697867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subunit interactions in the activation of cyclic nucleotide-gated ion channels.
    Varnum MD; Zagotta WN
    Biophys J; 1996 Jun; 70(6):2667-79. PubMed ID: 8744304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional significance of multimerization in ion channels.
    Tierney ML; Stowell MH
    Curr Opin Struct Biol; 1998 Apr; 8(2):186-8. PubMed ID: 9631291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrostatics and the ion selectivity of ligand-gated channels.
    Adcock C; Smith GR; Sansom MS
    Biophys J; 1998 Sep; 75(3):1211-22. PubMed ID: 9726923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of proton-induced current fluctuations in the human nicotinic acetylcholine receptor channel.
    Danelon C; Grandl J; Hovius R; Vogel H
    Biochim Biophys Acta; 2007 Jan; 1768(1):76-89. PubMed ID: 16956576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nicotinic receptor ligand binding domain.
    Sine SM
    J Neurobiol; 2002 Dec; 53(4):431-46. PubMed ID: 12436411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered Ionizable Side Chains.
    Cymes GD; Grosman C
    Adv Exp Med Biol; 2015; 869():5-23. PubMed ID: 26381938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying the Monod-Wyman-Changeux Allosteric Activation Model to Pseudo-Steady-State Responses from GABA
    Steinbach JH; Akk G
    Mol Pharmacol; 2019 Jan; 95(1):106-119. PubMed ID: 30333132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Relationship between Nicotinic Acetylcholine Receptor Ligand Size, Efficiency, Efficacy, and C-Loop Opening.
    Ma Q; Tae HS; Wu G; Jiang T; Yu R
    J Chem Inf Model; 2017 Aug; 57(8):1947-1956. PubMed ID: 28718646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.